)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Vaxcyte
Vaxcyte (PCVX) investor relations material
Vaxcyte AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary15 Jun, 2026
Opening remarks and agenda
Meeting called to order by the Chairman, with board members and key executives present.
Inspector of Election and representatives from Deloitte & Touche in attendance.
Voting procedures and eligibility clarified, with polls opened for voting.
Notice of meeting and affidavit of mailing incorporated into the minutes.
Shareholder proposals
Election of three Class III directors to serve until the 2029 Annual Meeting.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation as disclosed in the proxy statement.
Overview of voting outcomes
Quorum established with 95.13% of shares represented.
All board-recommended proposals passed according to preliminary voting results.
Results to be disclosed in a Form 8-K filing with the SEC.
Implications of the 95% shareholder turnout
Governance impact of the Class III director vote
Advisory nature of the executive pay resolution
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vaxcyte
- VAX-31 showed strong safety and broad immunogenicity, advancing to phase III for >95% coverage.PCVX
Study Result9 Jul 2026 - Upcoming infant phase II data may set a new standard for broad, potent pneumococcal protection.PCVXTD Cowen 45th Annual Healthcare Conference9 Jul 2026
- VAX-31's phase II success and broad coverage set the stage for market leadership and rapid growth.PCVX2024 Cantor Fitzgerald Global Healthcare Conference9 Jul 2026
- VAX-24 phase II in infants showed strong safety, broad immunogenicity, and robust booster responses.PCVXStudy Result8 Jul 2026
- 31-valent pneumococcal vaccine advances to phase three, with strong data and global growth prospects.PCVXGoldman Sachs 46th Annual Global Healthcare Conference8 Jul 2026
- VAX-31 advances as a high-coverage PCV leader, backed by strong data, market growth, and capital.PCVXJefferies Global Healthcare Conference 20251 Jul 2026
- Pivotal adult vaccine data and a novel Group A Strep program position the pipeline for leadership.PCVXJefferies Global Healthcare Conference 20263 Jun 2026
- Broad-spectrum vaccines advance with robust data and global market expansion opportunities.PCVXCorporate presentation3 Jun 2026
- VAX-31 aims for best-in-class pneumococcal coverage, with pivotal data expected Q4 2024.PCVXBank of America Global Healthcare Conference 202612 May 2026
Next Vaxcyte earnings date
Q2 20267 Aug, 2026
Vaxcyte
Next Vaxcyte earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage